[ed. note: Michael Jorrin, who I call Doc Gumshoe, is a longtime medical writer (not a doctor) who writes for us about medicine and health a couple times a month. He has agreed to our trading and disclosure restrictions, but does not generally write directly about investment ideas. His ideas, thoughts and words are his […]
Articles
The furor over gold in the past couple months has now leaked over into biotech land, with the FDA Trader newsletter from Agora Financial now catching your attention with the big bold word “GOLD” even as they pitch a “gold-based oncology protocol” that they say could set you up for 10,000% returns. Sounds a little […]
I’ve been seeing a groundswell of requests from readers to solve a teaser pitch about a little biotech stock, so that’s the plan for today… … and as usual with biotech, I’ll start with the caveat: I can ID the stock for you, I’m quite sure, but I can’t tell you much else about it. […]
Nicholas Vardy is out with a new biotech pick, and he says that he’s making an “unprecedented offer” for subscribers to his Bull Market Alert ($995/year “on sale”, published by Eagle Financial). The pitch is partly an argument that biotech and pharma stocks are still where the big opportunities are for investors, but most of […]
I’ve got a few stocks to mention in the medical space this week — one to update that’s in my portfolio, one to confirm as a teaser pick (since folks keep asking) after several Gumshoe readers discussed it last week, and one to note as a teaser idea that’s being pushed pretty heavily (though the […]
Just For the Record[Ed. note: Today we have another article from Jim Skelton, the Blind Squirrel, who is sharing his experiences as a financial advisor with us. He has agreed to our trading restrictions, the opinions he expresses are his own, and we haven’t reviewed, approved or screened his ideas. His previous articles can be seen here.] Hello, fellow […]
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
Comments
It's a bit late to recommend OPK !...
sorry that is OPK...
It's OPK ... I just checked the SEC website...
I'm absolutely convinced this is OPK now! I got the following email from Kyle today: ...Like it or not The country is g...
I believe he's talking about OPK (OPKO HEALTH INC). Here's a headline I found on briefing.com: Opko Health: FDA has auth...
Any changes in thought with opk with their covid testing capabilities?...
What does everyone think now? Still tons of insider share purchases. OPK about 1.60. They report after close on Wedne...
Travis, hi! Excellent work and i appreciate Gumshoe intellectual efforts. in the background, some fake news edited by b...
the start ups biotech are imprevisible even 0ne understands the matter. OPKO is developing an obvious necessary vitamin ...